These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 38003097)

  • 1. Evaluation of Renin-Angiotensin-Aldosterone System Components and Enzymes in Systemically Hypertensive Cats Receiving Amlodipine.
    Adin D; Atkins C; Domenig O; Glahn C; DeFrancesco T; Meurs K
    Animals (Basel); 2023 Nov; 13(22):. PubMed ID: 38003097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating renin-angiotensin-aldosterone system activity in cats with systemic hypertension or cardiomyopathy.
    Ward JL; Guillot E; Domenig O; Ware WA; Yuan L; Mochel JP
    J Vet Intern Med; 2022 May; 36(3):897-909. PubMed ID: 35285549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma renin activity and aldosterone concentrations in hypertensive cats with and without azotemia and in response to treatment with amlodipine besylate.
    Jepson RE; Syme HM; Elliott J
    J Vet Intern Med; 2014; 28(1):144-53. PubMed ID: 24428319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of amlodipine on the circulating renin-angiotensin-aldosterone system in healthy cats.
    Garcia Marrero TM; Ward JL; Tropf MA; Bourgois-Mochel A; Guillot E; Domenig O; Yuan L; Kundu D; Mochel JP
    J Vet Intern Med; 2024; 38(2):913-921. PubMed ID: 38334012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of calcifediol supplementation on renin-angiotensin-aldosterone system mediators in dogs with chronic kidney disease.
    Miller M; Quimby J; Langston C; Ames M; Parker VJ
    J Vet Intern Med; 2022 Sep; 36(5):1693-1699. PubMed ID: 35962709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of angiotensin-converting enzyme inhibition on plasma aldosterone concentration, plasma renin activity, and blood pressure in spontaneously hypertensive cats with chronic renal disease.
    Steele JL; Henik RA; Stepien RL
    Vet Ther; 2002; 3(2):157-66. PubMed ID: 19750747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the intrarenal renin-angiotensin system in cats with naturally occurring chronic kidney disease.
    Lourenço BN; Coleman AE; Berghaus RD; Tarigo JL; Schmiedt CW; Brown SA
    J Vet Intern Med; 2022 Mar; 36(2):647-655. PubMed ID: 35352404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of enalapril on furosemide-activated renin-angiotensin-aldosterone system in healthy dogs.
    Lantis AC; Ames MK; Werre S; Atkins CE
    J Vet Pharmacol Ther; 2015 Oct; 38(5):513-7. PubMed ID: 25771846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of subacute change in RAAS activity (as indicated by urinary aldosterone:creatinine, after pharmacologic provocation) and the response to ACE inhibition.
    Ames MK; Atkins CE; Lantis AC; zum Brunnen J
    J Renin Angiotensin Aldosterone Syst; 2016; 17(1):1470320316633897. PubMed ID: 27009288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of sex on renin-angiotensin-aldosterone system metabolites and enzymes in Doberman Pinschers.
    Adin DB; Hernandez JA
    J Vet Intern Med; 2023 Jan; 37(1):22-27. PubMed ID: 36412252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renin-angiotensin aldosterone profile before and after angiotensin-converting enzyme-inhibitor administration in dogs with angiotensin-converting enzyme gene polymorphism.
    Adin D; Atkins C; Domenig O; DeFrancesco T; Keene B; Tou S; Stern JA; Meurs KM
    J Vet Intern Med; 2020 Mar; 34(2):600-606. PubMed ID: 32112596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Effect of FGF23 on Cardiac Hypertrophy Is Not Mediated by Systemic Renin-Angiotensin- Aldosterone System in Hemodialysis.
    Dörr K; Kammer M; Reindl-Schwaighofer R; Lorenz M; Marculescu R; Poglitsch M; Beitzke D; Oberbauer R
    Front Med (Lausanne); 2022; 9():878730. PubMed ID: 35559350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triple pharmacological blockade of the renin-angiotensin-aldosterone system in nondiabetic CKD: an open-label crossover randomized controlled trial.
    Tylicki L; Rutkowski P; Renke M; Larczyński W; Aleksandrowicz E; Lysiak-Szydlowska W; Rutkowski B
    Am J Kidney Dis; 2008 Sep; 52(3):486-93. PubMed ID: 18423812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary angiotensin-converting enzyme 2 and its activity in cats with chronic kidney disease.
    Kuo TC; Hsu WL; Wu VC; Jan TR; Tsai PJ; Lee YJ
    Front Vet Sci; 2024; 11():1362379. PubMed ID: 38756510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renin-angiotensin-aldosterone system peptide profiles in patients with COVID-19.
    Kutz A; Conen A; Gregoriano C; Haubitz S; Koch D; Domenig O; Bernasconi L; Mueller B; Schuetz P
    Eur J Endocrinol; 2021 Apr; 184(4):543-552. PubMed ID: 33539316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renin-angiotensin-aldosterone system activity in hyperthyroid cats with and without concurrent hypertension.
    Williams TL; Elliott J; Syme HM
    J Vet Intern Med; 2013; 27(3):522-9. PubMed ID: 23517505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renin-angiotensin-aldosterone system blockers in Bulgarian COVID-19 patients with or without chronic kidney disease.
    Filev R; Rostaing L; Lyubomirova M; Bogov B; Kalinov K; Svinarov D
    Medicine (Baltimore); 2022 Dec; 101(48):e31988. PubMed ID: 36482641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Mineralocorticoid Receptor Antagonism and ACE Inhibition on Angiotensin Profiles in Diabetic Kidney Disease: An Exploratory Study.
    Kovarik JJ; Kaltenecker CC; Domenig O; Antlanger M; Poglitsch M; Kopecky C; Säemann MD
    Diabetes Ther; 2021 Sep; 12(9):2485-2498. PubMed ID: 34351585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperkalemia-Related Discontinuation of Renin-Angiotensin-Aldosterone System Inhibitors and Clinical Outcomes in CKD: A Population-Based Cohort Study.
    Leon SJ; Whitlock R; Rigatto C; Komenda P; Bohm C; Sucha E; Bota SE; Tuna M; Collister D; Sood M; Tangri N
    Am J Kidney Dis; 2022 Aug; 80(2):164-173.e1. PubMed ID: 35085685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma renin activity and angiotensin I and aldosterone concentrations in cats with hypertension associated with chronic renal disease.
    Jensen J; Henik RA; Brownfield M; Armstrong J
    Am J Vet Res; 1997 May; 58(5):535-40. PubMed ID: 9140564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.